Mellado OR, Escobar AE, De MMH, Díaz GEJ, Rodríguez WFL

Language: Spanish
References: 23
Page: 338-342
PDF size: 143.81 Kb.

ABSTRACT

Introduction: artificial intelligence has overcome the ability of some experts to diagnose and offer treatments with precision. It is estimated that a doctor should read more than 20 hours a day on medical literature to keep up. Watson for Oncology (WFO) system is a cognitive software designed to process sizeable medical literature focused on cancer patients and offer therapeutic options. Objective: to describe the concordance of adjuvant treatment for patients with breast cancer among a group of expert oncologists from Hospital Angeles Pedregal and the adjuvant treatment suggested by the Watson for Oncology system. Material and methods: it is a descriptive, single-center study at Hospital Angeles Pedregal, which included 58 patients diagnosed with breast cancer from January 2017 to December 2019. Results: adjuvant treatment by oncologists was 100% consistent with WFO system recommendations. 20% of the patients had a recommendation for adjuvant chemotherapy, and 25% had a recommendation for sequential chemotherapy with anthracyclines. Conclusions: the WFO system is software that has a high concordance with expert oncologists when it comes to suggesting adjuvant treatments for patients with breast cancer.

REFERENCES

1. Xu J, Yang P, Xue S, Sharma B, Sanchez-Martin M, Wang F et al. Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives. Hum Genet. 2019; 138 (2): 109-124.

2. Azuaje F. Artificial intelligence for precision oncology: beyond patient stratification. NPJ Precis Oncol. 2019; 3: 6.

3. Boon IS, Au Yong TPT, Boon CS. Assessing the role of artificial intelligence (AI) in clinical oncology: utility of machine learning in radiotherapy target volume delineation. Medicines (Basel). 2018; 5 (4): 131.

4. Kim EJ, Woo HS, Cho JH, Sym SJ, Baek JH, Lee WS et al. Early experience with Watson for Oncology in Korean patients with colorectal cancer. PLoS One. 2019; 14 (3): e0213640.

5. Zhou N, Zhang CT, Lv HY, Hao CX, Li TJ, Zhu JJ et al. Concordance study between IBM Watson for Oncology and clinical practice for patients with cancer in China. Oncologist. 2019; 24 (6): 812-819.

6. Patel NM, Michelini VV, Snell JM, Balu S, Hoyle AP, Parker JS et al. Enhancing next-generation sequencing-guided cancer care through cognitive computing. Oncologist. 2018; 23 (2): 179-185.

7. Norden AD, Dankwa-Mullan I, Urman A, Suarez F, Rhee K. Realizing the promise of cognitive computing in cancer care: ushering in a new era. JCO Clin Cancer Inform. 2018; 2: 1-6.

8. Chen Y, Elenee Argentinis JD, Weber G. IBM Watson: how cognitive computing can be applied to big data challenges in life sciences research. Clin Ther. 2016; 38 (4): 688-701.

9. Yang P, Xu L. The internet of things (IoT): informatics methods for iot-enabled health care. J Biomed Inform. 2018; 87: 154-156.

10. Kong HJ. Managing unstructured big data in healthcare system. Healthc Inform Res. 2019; 25 (1): 1-2.

11. Schwalbe N, Wahl B. Artificial intelligence and the future of global health. Lancet. 2020; 395 (10236): 1579-1586.

12. De Fauw J, Ledsam JR, Romera-Paredes B, Nikolov S, Tomasev N, Blackwell S et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat Med. 2018; 24 (9): 1342-1350.

13. Haenssle HA, Fink C, Schneiderbauer R, Toberer F, Buhl T, Blum A et al. Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists. Ann Oncol. 2018; 29 (8): 1836-1842.

14. Bejnordi BE, Veta M, Van Diest PJ, Van Ginneken B, Karssemeijer N, Litjens G et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA. 2017; 318 (22): 2199-2210.

15. Curioni-Fontecedro A. A new era of oncology through artificial intelligence. ESMO Open. 2017; 2 (2): e000198.

16. Vulsteke C, Arevalo M, Mouton C, Stam K, Goethals R, Ameye F et al. Artificial intelligence for the oncologist: hype, hubris, or reality? Belgian J Med Oncol. 2018; 12 (7): 330-333.

17. Noorbakhsh-Sabet N, Zand R, Zhang Y, Abedi V. Artificial intelligence transforms the future of health care. Am J Med. 2019; 132 (7): 795-801.

18. Lee WS, Ahn SM, Chung JW, Kim KO, Kwon KA, Kim Y et al. Assessing concordance with watson for Oncology, a cognitive computing decision support system for colon cancer treatment in Korea. JCO Clin Cancer Inform. 2018; 2: 1-8.

19. Krzyszczyk P, Acevedo A, Davidoff EJ, Timmins LM, Marrero-Berrios I, Patel M et al. The growing role of precision and personalized medicine for cancer treatment. Technology (Singap World Sci). 2018; 6 (3-4): 79-100.

20. Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov. 2004; 3 (8): 711-715.

21. Wang Z, Askamit I, Tuscher L, Bergstrom K. Rates of guideline adherence among US community oncologists treating NSCLC. Am J Manag Care. 2013; 19 (3): 185-192.

22. Tupasela A, Di Nucci E. Concordance as evidence in the Watson for Oncology decision-support system. AI Soc. 2020; 35 (4): 811-818.

23. Somashekhar SP, Sepúlveda MJ, Puglielli S, Norden AD, Shortliffe EH, Rohit Kumar C et al. Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board. Ann Oncol. 2018; 29 (2): 418-423.